Chemical Structure (Medrol 01)
Medrol
Product Images NDC 67296-1821
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Medrol (NDC 67296-1821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Medrol 02)
Principal Display Panel (4 mg Tablet Bottle Label)
This text provides information about storing medication at room temperature, protecting it from light, and dispensing it in a tight, light-resistant container. It mentions the medication Medrol containing methylprednisolone tablets and advises patients to follow the dosage instructions provided. It also includes details about the distributor and the prescription number. This text does not include any non-English characters.*
Principal Display Panel (4 mg Tablet Dose Pack)
This text contains information about Medrol® Dosepak tablets to be taken at different times of the day: before breakfast, after lunch, after dinner, and at bedtime. It also provides details on how to take the tablets and precautions to follow. The product is distributed by Pharmacia & Upjohn Co. division of Pfizer Inc.*
Principal Display Panel (4 mg Tablet Dose Pack Carton)
This text describes a medication called "Medrol Dosepak" which contains methylprednisolone tablets. The packaging includes one blister containing 21 tablets. It provides information on storage conditions, dosage, and use instructions. The tablets contain 4 mg of methylpredrisolone each. The package is child-resistant and should be kept out of reach of children. For detailed dosage and usage instructions, refer to the accompanying prescribing information.*
Principal Display Panel (8 mg Tablet Bottle Label)
This is a medication label for Medrol tablets containing methylprednisolone, USP. The storage instructions indicate keeping the tablets at controlled room temperature between 20° to 25°C and protected from light in child-resistant containers. Patients should be closely monitored by a physician when using this medication. For dosage and usage information, refer to the accompanying prescribing information. The tablets are distributed by Pharmaci & Ugiom Co, Division 1 in NY.*
Principal Display Panel (16 mg Tablet Bottle Label)
Principal Display Panel (32 mg Bottle Tablet Label)
Store the medication at a controlled room temperature between 20° to 25°C (68° to 77°F) to protect it from light. These methylprednisolone tablets are dispensed in child-resistant containers as per USP guidelines and should be kept out of reach and sight of children under the close supervision of a physician. Each tablet contains 32 mg of methylprednisolone, USP. It is essential to refer to the accompanying prescribing information for dosage and usage instructions. This product is available in a pack with 25 tablets and is only available through prescription.*
Principal Display Panel (2 mg Tablet Bottle Label)
This text provides important information about the storage conditions, handling instructions, and dosage information for Medrol® (methylprednisolone tablets). It indicates that the tablets should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and protected from light. Dispensing should be done in tight, child-resistant containers. Patients should be closely observed by a physician, and the dosing and usage details can be found in the accompanying prescribing information. Each tablet contains 2 mg of methylprednisolone, USP. The product is distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
